La maladie de Parkinson au Canada (serveur d'exploration) - Checkpoint (PubMed)

Index « Mesh.i » - entrée « Central Nervous System Stimulants »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Central Nervous System Diseases < Central Nervous System Stimulants < Cephalometry  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 10.
Ident.Authors (with country if any)Title
000B03 (2012) Ronald B. Postuma [Canada] ; Anthony E. Lang ; Renato P. Munhoz ; Katia Charland ; Amelie Pelletier ; Mariana Moscovich ; Luciane Filla ; Debora Zanatta ; Silvia Rios Romenets ; Robert Altman ; Rosa Chuang ; Binit ShahCaffeine for treatment of Parkinson disease: a randomized controlled trial.
000D06 (2010) Russell C. Callaghan [Canada] ; James K. Cunningham ; Gautam Sajeev ; Stephen J. KishIncidence of Parkinson's disease among hospital patients with methamphetamine-use disorders.
000F06 (2008) Karim Mukhida [Canada] ; Behnam A. Baghbaderani ; Murray Hong ; Matthew Lewington ; Timothy Phillips ; Marcus Mcleod ; Arindom Sen ; Leo A. Behie ; Ivar MendezSurvival, differentiation, and migration of bioreactor-expanded human neural precursor cells in a model of Parkinson disease in rats.
000F48 (2008) Isabelle Boileau [Canada] ; Pablo Rusjan ; Sylvain Houle ; Diana Wilkins ; Junchao Tong ; Peter Selby ; Mark Guttman ; Jean A. Saint-Cyr ; Alan A. Wilson ; Stephen J. KishIncreased vesicular monoamine transporter binding during early abstinence in human methamphetamine users: Is VMAT2 a stable dopamine neuron biomarker?
001032 (2007) Dan A. Mendonça [Canada] ; Krishe Menezes ; Mandar S. JogMethylphenidate improves fatigue scores in Parkinson disease: a randomized controlled trial.
001117 (2006) Kaveh M. Koochesfahani [Canada] ; Raúl De La Fuente-Fernández ; Vesna Sossi ; Michael Schulzer ; Lakshmi N. Yatham ; Thomas J. Ruth ; Stephan Blinder ; A Jon StoesslOral methylphenidate fails to elicit significant changes in extracellular putaminal dopamine levels in Parkinson's disease patients: positron emission tomographic studies.
001550 (2000) I. Mendez [Canada] ; K A Baker ; M. HongSimultaneous intrastriatal and intranigral grafting (double grafts) in the rat model of Parkinson's disease.
001723 (1998) P. Seeman [Canada] ; B K MadrasAnti-hyperactivity medication: methylphenidate and amphetamine.
001C57 (????) David K. Simon [Singapour] ; Cai Wu ; Barbara C. Tilley ; Anne-Marie Wills ; Michael J. Aminoff ; Jacquelyn Bainbridge ; Robert A. Hauser ; Jay S. Schneider ; Saloni Sharma ; Carlos Singer ; Caroline M. Tanner ; Daniel Truong ; Pei Shieen WongCaffeine and Progression of Parkinson Disease: A Deleterious Interaction With Creatine.
001D04 (????) Anette V. Nieves [Canada] ; Anthony E. LangTreatment of excessive daytime sleepiness in patients with Parkinson's disease with modafinil.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/PubMed/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Mesh.i -k "Central Nervous System Stimulants" 
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Mesh.i  \
                -Sk "Central Nervous System Stimulants" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Central Nervous System Stimulants
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022